Junliang Fu

8.3k total citations · 1 hit paper
90 papers, 4.7k citations indexed

About

Junliang Fu is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Junliang Fu has authored 90 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 40 papers in Immunology and 36 papers in Hepatology. Recurrent topics in Junliang Fu's work include Hepatitis B Virus Studies (37 papers), Immune Cell Function and Interaction (27 papers) and Hepatitis C virus research (26 papers). Junliang Fu is often cited by papers focused on Hepatitis B Virus Studies (37 papers), Immune Cell Function and Interaction (27 papers) and Hepatitis C virus research (26 papers). Junliang Fu collaborates with scholars based in China, United States and Hong Kong. Junliang Fu's co-authors include Fu‐Sheng Wang, Zheng Zhang, Ming Shi, Zhengsheng Zou, Ji‐Yuan Zhang, Chun‐Bao Zhou, Ruonan Xu, Hui Zhang, Lei Jin and Lei Jin and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Junliang Fu

83 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients

2007 725 citations Junliang Fu, Zhenwen Liu et al. Gastroenterology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junliang Fu China	29	2.2k	1.8k	1.6k	915	638	90	4.7k
Ming Shi China	27	1.8k 0.8×	1.5k 0.8×	1.3k 0.8×	791 0.9×	752 1.2×	91	4.2k
Jaap Kwekkeboom Netherlands	44	2.8k 1.3×	1.1k 0.6×	1.2k 0.7×	1.7k 1.9×	1.0k 1.6×	161	6.0k
Bertram Bengsch Germany	30	3.3k 1.5×	1.1k 0.6×	872 0.5×	1.5k 1.6×	440 0.7×	73	4.9k
Su‐Hyung Park South Korea	36	1.9k 0.8×	946 0.5×	884 0.5×	1.2k 1.3×	176 0.3×	116	4.2k
Pablo Sarobe Spain	39	2.6k 1.2×	935 0.5×	1.5k 0.9×	2.0k 2.2×	271 0.4×	125	5.5k
Michael Geißler Germany	34	818 0.4×	825 0.5×	755 0.5×	1.5k 1.6×	581 0.9×	151	3.5k
Akifumi Takaori‐Kondo Japan	42	1.9k 0.8×	861 0.5×	175 0.1×	1.2k 1.3×	376 0.6×	288	5.8k
Dave Sprengers Netherlands	36	1.3k 0.6×	954 0.5×	1.1k 0.7×	1.3k 1.5×	377 0.6×	101	3.5k
Andreas Limmer Germany	31	2.2k 1.0×	695 0.4×	600 0.4×	642 0.7×	231 0.4×	45	3.4k
Hans Reiser United States	37	2.7k 1.2×	803 0.4×	423 0.3×	513 0.6×	127 0.2×	62	4.1k

Countries citing papers authored by Junliang Fu

Since Specialization

Citations

This map shows the geographic impact of Junliang Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Fu more than expected).

Fields of papers citing papers by Junliang Fu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junliang Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Fu. The network helps show where Junliang Fu may publish in the future.

Co-authorship network of co-authors of Junliang Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Junliang Fu. A scholar is included among the top collaborators of Junliang Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junliang Fu. Junliang Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Horng‐Dar, Xin Zhang, Yaping Li, et al.. (2025). Safety and efficacy of PD-1 antibody combined with pegylated interferon α for functional cure in nucleos(t)ide analogues-suppressed chronic hepatitis B patients: protocol for a multicentre randomised controlled trial. BMJ Open. 15(9). e105710–e105710.

Fu, Junliang, Jiayi Li, Shuanglong Lin, et al.. (2024). N-Halosuccinimide enables cascade oxidative trifluorination and halogenative cyclization of tryptamine-derived isocyanides. Nature Communications. 15(1). 8917–8917. 9 indexed citations

Fu, Junliang, et al.. (2024). Baseline and Dynamic MAF-5 Score to Predict Liver Fibrosis and Liver-Related Events in General Population With MASLD. Clinical Gastroenterology and Hepatology. 23(2). 365–368.e3. 2 indexed citations

Xie, Yunbo, Penghui Yang, Xi Chen, et al.. (2024). Safety, immunogenicity and protective effect of sequential vaccination with inactivated and recombinant protein COVID-19 vaccine in the elderly: a prospective longitudinal study. Signal Transduction and Targeted Therapy. 9(1). 129–129. 4 indexed citations

Lou, Xin, Yingying Gao, Jiaye Liu, et al.. (2022). Quantitative anti-HBc combined with quantitative HBsAg can predict HBsAg clearance in sequential combination therapy with PEG-IFN-α in NA-suppressed chronic hepatitis B patients. Frontiers in Immunology. 13. 894410–894410. 16 indexed citations

Yuan, Xin, Zhe Xu, Lei Huang, et al.. (2022). Effect of methylprednisolone therapy on hospital stay and viral clearance in patients with moderate COVID-19. SHILAP Revista de lepidopterología. 1(4). 236–244. 1 indexed citations

Gao, Yanan, Junliang Fu, Meijie Tian, et al.. (2021). Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B. Journal of Hepatology. 76(1). 148–159. 114 indexed citations

Tu, Bo, Junliang Fu, Xing‐Ding Zhang, et al.. (2016). Clinical and immunological analysis of measles patients admitted to a Beijing hospital in 2014 during an outbreak in China. Epidemiology and Infection. 144(12). 2613–2620. 5 indexed citations

Zhou, Lin, Huaming Wang, Junliang Fu, et al.. (2013). Study on the correlation between CD4~+ cytotoxic T and course of primary hepatocellular carcinoma. Jiefangjun yixue zazhi. 38(2). 137–140. 1 indexed citations

10.

Zhang, Zheng, Junliang Fu, Siyu Wang, et al.. (2013). Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients. AIDS. 27(8). 1283–1293. 58 indexed citations

11.

Lin, Hu, Zheng Zhang, Ming Shi, et al.. (2012). Evaluation on the efficacy of human umbilical cord derived-mesenchymal stem cell transplantation in liver cirrhosis patients with ascites in a prospective and control trial. 30(4). 204–208. 3 indexed citations

12.

Zhang, Zheng, Hu Lin, Ming Shi, et al.. (2012). Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. Journal of Gastroenterology and Hepatology. 27(s2). 112–120. 273 indexed citations

13.

Tang, Zirong, Ming Shi, Bing Zhang, et al.. (2011). Effect of treatment of autologous cytokine-induced killer cells(CIKs) on the suppression of hepatitis B virus and its mechanism. Jiefangjun yixue zazhi. 36(9). 901–903.

14.

Zhang, Zheng, Shuye Zhang, Zhengsheng Zou, et al.. (2010). Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology. 53(1). 73–85. 130 indexed citations

15.

Shi, Ming, Junliang Fu, Shi Feng, et al.. (2009). Transfusion of autologous cytokine-induced killer cells inhibits viral replication in patients with chronic hepatitis B virus infection. Clinical Immunology. 132(1). 43–54. 20 indexed citations

16.

Zhang, Ji‐Yuan, Zheng Zhang, Bo Jin, et al.. (2008). Cutting Edge: Programmed Death-1 Up-Regulation Is Involved in the Attrition of Cytomegalovirus-Specific CD8+ T Cells in Acute Self-Limited Hepatitis B Virus Infection. The Journal of Immunology. 181(6). 3741–3744. 23 indexed citations

17.

Fu, Junliang, Zhenwen Liu, Ming Shi, et al.. (2007). Increased Regulatory T Cells Correlate With CD8 T-Cell Impairment and Poor Survival in Hepatocellular Carcinoma Patients. Gastroenterology. 132(7). 2328–2339. 725 indexed citations breakdown →

18.

Zhang, Zheng, Junliang Fu, Qingxia Zhao, et al.. (2006). Differential Restoration of Myeloid and Plasmacytoid Dendritic Cells in HIV-1-Infected Children after Treatment with Highly Active Antiretroviral Therapy. The Journal of Immunology. 176(9). 5644–5651. 48 indexed citations

19.

Xu, Dongping, Junliang Fu, Lei Jin, et al.. (2006). Circulating and Liver Resident CD4+CD25+ Regulatory T Cells Actively Influence the Antiviral Immune Response and Disease Progression in Patients with Hepatitis B. The Journal of Immunology. 177(1). 739–747. 373 indexed citations

20.

Zhao, Ping, et al.. (2004). [IFN or oxymatrine in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B].. PubMed. 18(1). 80–2. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact